Research output per year
Research output per year
Personal profile
Research interests
- Radiomics quantitative analysis on PET-CT in Hodgkin lymphoma
- Epidemiology of Hodgkin lymphoma
- Development of a prognostic model for relapsed and refractory Hodgkin lymphoma using imaging (PET-CT) and biomarkers (TARC).
specialisation
Hematology
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Research output
- 9 Article
-
Disaggregating the dementia monolith: An analysis of variation in Medicare costs and use by dementia subtype
Parasrampuria, S., Bijelic, E., Bott, D. M., Driessen, J., Lipp, M. J. & Ling, S. M., Aug 2023, In: Alzheimer s & dementia. 19, 8, p. 3295-3305 11 p.Research output: Contribution to journal › Article › Academic › peer-review
-
Prognostic model using 18F-FDG PET radiomics predicts progression-free survival in relapsed/refractory Hodgkin lymphoma
Driessen, J., Zwezerijnen, G. J. C., Schöder, H., Kersten, M. J., Moskowitz, A. J., Moskowitz, C. H., Eertink, J. J., Heymans, M. W., Boellaard, R. & Zijlstra, J. M., 2023, In: Blood advances. 7, 21, p. 6732-6743 12 p.Research output: Contribution to journal › Article › Academic › peer-review
Open Access1 Citation (Scopus) -
Prognostic value of TARC and quantitative PET parameters in relapsed or refractory Hodgkin lymphoma patients treated with brentuximab vedotin and DHAP
On behalf of the HOVON Lunenburg Lymphoma Phase I/II Consortium (LLPC), Dec 2022, In: Leukemia. 36, 12, p. 2853-2862 10 p.Research output: Contribution to journal › Article › Academic › peer-review
Open Access7 Citations (Scopus) -
The Impact of Semiautomatic Segmentation Methods on Metabolic Tumor Volume, Intensity, and Dissemination Radiomics in 18F-FDG PET Scans of Patients with Classical Hodgkin Lymphoma
Driessen, J., Zwezerijnen, G. J. C., Schöder, H., Drees, E. E. E., Kerstenjavascript:void(0);, M. J., Moskowitz, A. J., Moskowitz, C. H., Eertink, J. J., Vet, H. C. W. D., Hoekstra, O. S., Zijlstra, J. M. & Boellaard, R., 1 Sept 2022, In: Journal of nuclear medicine. 63, 9, p. 1424-1430 7 p.Research output: Contribution to journal › Article › Academic › peer-review
Open Access17 Citations (Scopus) -
Combining brentuximab vedotin with dexamethasone, high-dose cytarabine and cisplatin as salvage treatment in relapsed or refractory Hodgkin lymphoma: the phase II HOVON/LLPC Transplant BRaVE study
Kersten, M. J., Driessen, J., Zijlstra, J. M., Plattel, W. J., Morschhauser, F., Lugtenburg, P. J., Brice, P., Hutchings, M., Gastinne, T., Liu, R., Burggraaff, C. N., Nijland, M., Tonino, S. H., Arens, A. I. J., Valkema, R., van Tinteren, H., Lopez-Yurda, M., Diepstra, A., De Jong, D. & Hagenbeek, A., 1 Apr 2021, In: Haematologica. 106, 4, p. 1129-1137 9 p.Research output: Contribution to journal › Article › Academic › peer-review
Open Access54 Citations (Scopus)